Fueling Research, Feeding Discovery

New Products

Comprehensive assay kits for drug screening

  • Kit Solutions

    Kit Solutions

    AntBio offers mIHC kits, organoid culture kits, conventional and One-step ELISA assay kits, RNA/DNA/protein interaction kits, etc.

  • Cytokine Solutions

    Cytokine Solutions

    AntBio provides related cytokines of different cell types (organoids, stem cells, immune cells, etc.) with high purity and high activity verification

  • Target Protein Solutions

    Target Protein Solutions

    AntBio offers high performance target proteins in different research areas (antibody drugs, ADC drugs, CAR-T, small molecule drugs, etc.)

  • Loading Control

    Loading Control

    AntBio offers reliable and high-quality loading control antibodies, essential for accurate normalization in Western blotting and other protein quantification assays.

Featured Products

Essential Cytokines Special Offer

Cytokines as low as $29

15 Jul – 31 Aug, 2026

View Promotions

20% off for 5+ items

Enjoy 20% discount on 5 or more items storewide including OneStep ELISA Kits, mIHC Kits, IHC antibodies, Organoid Culture Kits, PTMs antibodies and so on.

Promo Period: 1 July 2026 to 31 Dec 2026

View Promotions

New Semester Launch | Spacial Biology

Discount Code: ANT2608@20

Promotion valid from 15 Aug to 31 Oct, 2026

View Promotions
bg

About Us

AntBio - Fueling Research, Feeding Discovery

AntBio is a biotechnology group company dedicated to serving life sciences, aiming to help scientists accelerate research and improve work efficiency. AntBio provides comprehensive and high-quality reagent tools for basic research, drug development, and diagnosis, including research grade antibodies, proteins, biochemical reagents, and assay kits. These research tools are widely used in different segments of life science research. The group company currently consists of three brands, Absin, Starter-Bio and UA-Bio.

About Us

50k

Happy Clients

100k

Products

70+

Doctor/Expert

20,000+

Publications

ARTICLES

Latest News

21 Aug 2026 by AntBio
Innovative Directions for Modern Biopharma Antibody‑Discovery and Antibody‑Engineered Therapeutic Basic‑Research

Innovative Directions for M...

This biopharma‑R&D review analyses innovative antibody‑drug development directions covering ADC, multispecific‑antibodies, antibody‑fragments, nanobodies and antibody‑cytokine‑fusion‑proteins. It introduces end‑to‑end industrial‑grade custom antibody‑discovery service from ANT BIO PTE. LTD for target‑validation, lead‑candidate‑screening,...

Innovative Directions for M...

This biopharma‑R&D review analyses innovative antibody‑drug development directions covering ADC, multispecific‑antibodies, antibody‑fragments, nanobodies and antibody‑cytokine‑fusion‑proteins. It introduces end‑to‑end industrial‑grade custom...

View Details
PTEN Tumour‑Suppressor: Decoding Gene‑Inactivation Mechanisms for Pre‑Clinical Precision‑Oncology Basic‑Research

PTEN Tumour‑Suppressor: Decoding Gene...

This oncology‑biology review explains PTEN tumour‑suppressor molecular functions, PI3K‑AKT‑mTOR / MAPK / FAK signalling‑axis regulation, PTEN‑loss‑driven therapeutic‑resistance to immune‑checkpoint‑blockade and pre‑clinical combination‑treatment research. It lists PTEN‑series recombinant rabbit mAbs (S0B2105,...

PTEN Tumour‑Suppressor: Decoding Gene...

This oncology‑biology review explains PTEN tumour‑suppressor molecular functions, PI3K‑AKT‑mTOR / MAPK / FAK signalling‑axis regulation, PTEN‑loss‑driven therapeutic‑resistance to immune‑checkpoint‑blockade and...

View Details
Phosphorylated PLCγ1 (Tyr783): Regulating Liquid‑Liquid Phase Separation Within T‑Cell Receptor Signalling Cascades

Phosphorylated PLCγ1 (Tyr783): Regula...

This adaptive‑immunology signalling review interprets liquid‑liquid phase separation (LLPS) of LAT signalling condensates, dual enzymatic‑scaffold functions of PLCγ1, SH2‑domain‑mediated LAT cross‑linking, CD45‑dephosphorylation shielding and non‑monotonic concentration‑dependent LLPS regulation. It features...

Phosphorylated PLCγ1 (Tyr783): Regula...

This adaptive‑immunology signalling review interprets liquid‑liquid phase separation (LLPS) of LAT signalling condensates, dual enzymatic‑scaffold functions of PLCγ1, SH2‑domain‑mediated LAT...

View Details
PIK3CG (p110γ): Uncovering Potential Targets for Mechanistic Studies of Sepsis‑Induced Myocardial Injury

PIK3CG (p110γ): Uncovering Potential ...

This inflammation‑cardiology review interprets multi‑omics identification of PIK3CG (p110γ) as hub gene in sepsis‑triggered myocardial injury, dual inflammatory‑cardioprotective functions of PI3Kγ, melatonin‑PIK3CG molecular‑docking findings and pre‑clinical animal‑model observations. It provides...

PIK3CG (p110γ): Uncovering Potential ...

This inflammation‑cardiology review interprets multi‑omics identification of PIK3CG (p110γ) as hub gene in sepsis‑triggered myocardial injury, dual inflammatory‑cardioprotective functions of...

View Details